Author:
Din Usama Abdel Azim Sharaf El,Salem Mona Mansour,Abdulazim Dina Ossama
Publisher
Baishideng Publishing Group Inc.
Reference201 articles.
1. Prevalence of Chronic Kidney Disease in the United States
2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
3. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
4. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860.
5. Haller H. CCL2 inhibition with emapticap pegol (NOX‐E36) in type 2 diabetic patients with albuminuria. Late breaking clinical trials. The ERA-EDTA 51st congress, 2014, Sunday, June 1st. Available from: http://www.era-edta2014.org/en-US/symposium-1..
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献